每經AI快訊，5月(yue)13日(ri)，華潤(run)雙(shuang)鶴(he)公(gong)(gong)告，全(quan)資(zi)(zi)子(zi)公(gong)(gong)司華潤(run)雙(shuang)鶴(he)利民(min)藥(yao)業(ye)(濟南(nan))有限(xian)(xian)公(gong)(gong)司收(shou)到(dao)了(le)國(guo)家藥(yao)品(pin)監督管(guan)理局(ju)頒發(fa)的吡拉西坦注射液《藥(yao)品(pin)補充申(shen)請(qing)批(pi)準(zhun)(zhun)通知書》，全(quan)資(zi)(zi)子(zi)公(gong)(gong)司上海長征富民(min)金山制藥(yao)有限(xian)(xian)公(gong)(gong)司收(shou)到(dao)了(le)國(guo)家藥(yao)品(pin)監督管(guan)理局(ju)頒發(fa)的腹(fu)膜透(tou)析(xi)液(乳(ru)酸(suan)(suan)(suan)鹽(yan)(yan)G1.5%)、腹(fu)膜透(tou)析(xi)液(乳(ru)酸(suan)(suan)(suan)鹽(yan)(yan)-G2.5%)、腹(fu)膜透(tou)析(xi)液(乳(ru)酸(suan)(suan)(suan)鹽(yan)(yan)-G4.25%)系列產品(pin)《藥(yao)品(pin)補充申(shen)請(qing)批(pi)準(zhun)(zhun)通知書》。